Physician profile
Gregory J Oleyourryk
NPI 1811912959
$10,695.87
in general payments reported to CMS, 2019-2025
52 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $1,054 · 2021: $626 · 2022: $1,304 · 2023: $1,917 · 2024: $2,365 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,445 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,445.35 |
| Education | $170.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,014.02 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $1,179.55 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,056.09 | 2019-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $796.23 | 2019-2025 | Provenge |
| Pfizer INC. | $544.03 | 2019-2025 | |
| Abbvie INC. | $499.78 | 2021-2025 | |
| Antares Pharma, INC. | $412.21 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Ferring Pharmaceuticals INC. | $378.67 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $333.30 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Coloplast Corp | $295.67 | 2022-2025 | Speedicath |
| Urogen Pharma, INC. | $251.50 | 2022-2024 | Jelmyto |
| Neotract INC. | $226.95 | 2020 | |
| Teleflex LLC | $198.05 | 2022-2024 | Urolift |
| Procept Biorobotics Corporation | $180.09 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Urovant Sciences INC | $149.45 | 2021-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $148.52 | 2024-2025 | Posluma |
| 180 Medical, INC. | $143.41 | 2019-2023 | Gentlecath Glide, Cure Catheter |
| Myriad Genetic Laboratories, INC. | $141.29 | 2020-2025 | Prolaris |
| Telix Pharmaceuticals | $139.14 | 2022-2025 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $134.12 | 2019-2022 | |
| Accord Healthcare, INC. | $111.86 | 2023-2025 | |
| Calyxo, INC. | $111.71 | 2024-2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $89.26 | 2019-2023 | Aveed, Xiaflex, Edex |
| Medtronic, INC. | $84.35 | 2021-2024 | Interstim |
| Dentsply Ih Ab | $83.43 | 2025 | Lofric |
| Biotissue Holdings INC. | $73.04 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.63 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $64.63 | 2024 | Bard Urinary Drainage Bag |
| Zyla Life Sciences, INC. | $55.57 | 2019-2020 | |
| Tolmar, INC. | $55.52 | 2023-2025 | Jatenzo, Eligard |
| Allergan, INC. | $53.20 | 2019-2022 | |
| Olympus America INC. | $52.74 | 2023-2024 | Itind System |
| Novo Nordisk INC | $52.64 | 2024 | Rivfloza |
| Cook Medical LLC | $44.13 | 2019-2024 | Litho 150 |
| Boston Scientific Corporation | $42.69 | 2025 | General - Female Sui |
| Progenics Pharmaceuticals, INC. | $39.50 | 2022-2025 | |
| Clarus Therapeutics INC. | $36.98 | 2021 | |
| Immunitybio, INC. | $34.22 | 2024-2025 | |
| Amgen INC. | $33.59 | 2020-2022 | |
| Rochester Medical Corporation | $30.14 | 2019 | |
| Foundation Medicine, INC. | $30.05 | 2019-2021 | |
| Ethicon US, LLC | $28.54 | 2025 | Vistaseal |
| Janssen Pharmaceuticals, INC | $27.18 | 2019-2021 | |
| Ambu INC. | $26.25 | 2020 | |
| Endo USA, INC. | $23.89 | 2025 | Xiaflex, Aveed |
| Valencia Technologies Corporation | $22.75 | 2025 | Ecoin Device Kit |
| Travere Therapeutics, INC. | $20.53 | 2019 | |
| Therapeuticsmd, INC. | $19.40 | 2020 | |
| Amniox Medical, INC. | $17.43 | 2020 | |
| Medtronic USA, INC. | $15.33 | 2019 | |
| Myovant Sciences INC. | $13.60 | 2021 | |
| Sagent Pharmaceuticals | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Oleyourryk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.